Evidence map›Paper›PMID 36388783›Full record

ArticleAnnals of translational medicine2022

Cucurbitacin promotes hair growth in mice by inhibiting the expression of fibroblast growth factor 18.

Keke Guo, Lusheng Wang, Yulan Zhong, Shuang Gao, Rongrong Jing, Jiabin Ye, Kaini Zhang, Mengli Fu, Zhenlin Hu, Wengang Zhao and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Keke Guo *College of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Lusheng Wang *College of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Yulan Zhong *College of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Shuang GaoSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Rongrong JingCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Jiabin YeCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Kaini ZhangCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Mengli FuCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Zhenlin HuSchool of Medicine, Shanghai University, Shanghai, China.
Wengang ZhaoInstitute of Life Sciences, Wenzhou University, Wenzhou, China.
Nuo XuCollege of Life and Environmental Sciences, Wenzhou University, Wenzhou, China.
Wenzhou University · CNShanghai University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The inhibition of fibroblast growth factor 18 (FGF18) promotes the transition of hair follicles (HFs) from the telogen phase to the anagen phase. Cucurbitacin has been shown to have a good effect in promoting hair cell growth. This study explored the potential effect of cucurbitacin on hair growth and its effect on FGF18 expression in mice. Methods: Male C57BL/6J mice were randomly divided into the following two groups: (I) the vehicle group; and (II) the cucurbitacin group. Matrix cream and cucurbitacin cream were applied to the depilated skin on the back of the vehicle group mice and the cucurbitacin group mice, respectively. On days 3, 6, 9, 12, 15, and 18, the hair growth in the depilated dorsal skin of the mice was recorded with a digital camera and a HF detector, and the HF cycle status of the mice was observed by hematoxylin and eosin (H&E) staining. In addition, the level of FGF18 messenger ribonucleic acid (mRNA) in the dorsal skin was measured on days 15 and 18 by quantitative real-time polymerase chain reaction (qRT-PCR), while the level of FGF18 protein was measured by western blot and immunofluorescence staining. Results: The dorsal skin to which the cucurbitacin cream was applied began to darken on day 6 and grew hairs on day 9, which was 3 days earlier than the dorsal skin to which the matrix cream was applied. The H&E staining revealed a transition from the telogen phase to the anagen phase 3 days earlier for the cucurbitacin cream-treated skin than the matrix cream-treated skin. In addition, the skin treated with cucurbitacin cream also showed a significant decrease in FGF18 mRNA as seen by qRT-PCR, and reduced FGF18 protein levels as detected by western blot and immunofluorescence staining compared to the skin treated with matrix cream only. Conclusions: Cucurbitacin significantly reduced the levels of FGF18 mRNA and protein in the dorsal skin of mice to accelerate the HFs to enter the anagen phase earlier, thereby promoting the regeneration of hair. Thus, cucurbitacin can be considered a new and valuable agent for the development of anti-hair loss products.

Indexed as

Cucurbitacinfibroblast growth factor 18 (FGF18)hair follicle cycle

Identifiers

PMID36388783
PMCPMC9652544
OpenAlexW4309412281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.